The Gene expression Grade Index: a potential predictor of relapse for endocrine-treated breast cancer patients in the BIG 1–98 trial

BACKGROUND: We have previously shown that the Gene expression Grade Index (GGI) was able to identify two subtypes of estrogen receptor (ER)-positive tumors that were associated with statistically distinct clinical outcomes in both untreated and tamoxifen-treated patients. Here, we aim to investigate...

Descripción completa

Detalles Bibliográficos
Autores principales: Desmedt, Christine, Giobbie-Hurder, Anita, Neven, Patrick, Paridaens, Robert, Christiaens, Marie-Rose, Smeets, Ann, Lallemand, Françoise, Haibe-Kains, Benjamin, Viale, Giuseppe, Gelber, Richard D, Piccart, Martine, Sotiriou, Christos
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713270/
https://www.ncbi.nlm.nih.gov/pubmed/19573224
http://dx.doi.org/10.1186/1755-8794-2-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713270/
https://www.ncbi.nlm.nih.gov/pubmed/19573224
http://dx.doi.org/10.1186/1755-8794-2-40

Ejemplares similares